Relmada Therapeutics (RLMD) Change in Receivables (2016 - 2023)
Relmada Therapeutics (RLMD) reported Change in Receivables of -$512432.0 for Q1 2023, down 6906.11% quarter-over-quarter from $7529.0 in Q1 2020.
Relmada Therapeutics (RLMD) Change in Receivables (2016 - 2023) Analysis & Trends
Relmada Therapeutics (RLMD) has 6 years of Change in Receivables data on file, last reported at -$512432.0 in Q1 2023.
- Change in Receivables for Q1 2023 came in at -$512432.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was -$512432.0 (changed N/A YoY), and the FY2023 annual result was -$512432.0, down 200.0% from the prior year.
- Change in Receivables retreated to -$512432.0 in Q1 2023 per RLMD's latest filing, from $7529.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $176980.0 in Q2 2019 and troughed at -$512432.0 in Q1 2023.
- A 3-year average of -$136376.6 and a median of -$176980.0 in 2019 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 2223.49% in 2019 and fell as far as 2223.49% in 2019.
- A 3-year view of Change in Receivables shows it stood at -$176980.0 in 2019, then jumped by 104.25% to $7529.0 in 2020, then slumped by 6906.11% to -$512432.0 in 2023.
- Business Quant data shows RLMD's Change in Receivables at -$512432.0 in Q1 2023, $7529.0 in Q1 2020, and -$176980.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Relmada Therapeutics | 581.07 Mn | 581.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -512,432.00 |
| Mar 31, 2023 | -512,432.00 |
| Mar 31, 2020 | 7,529.00 |
| Mar 31, 2020 | 7,529.00 |
| Dec 31, 2019 | -176,980.00 |
| Dec 31, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Jun 30, 2019 | 176,980.00 |
| Jun 30, 2019 | 176,980.00 |
| Sep 30, 2018 | -7,617.00 |
| Sep 30, 2018 | -7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Sep 30, 2017 | -81,980.00 |
| Sep 30, 2017 | -81,980.00 |
| Sep 30, 2016 | 2,350.00 |
| Sep 30, 2016 | 2,350.00 |